Journal
PHARMACEUTICAL BIOLOGY
Volume 54, Issue 12, Pages 2895-2900Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/13880209.2016.1190764
Keywords
Cardiac energy metabolism; carnitine palmitoyltransferase-1a; glucose transporter-4; peroxisome proliferator-activated receptor alpha; pyruvate dehydrogenase kinase-4
Ask authors/readers for more resources
Context: Chrysanthemum morifolium Ramat. (Asteraceae) extract (CME) possesses a vasodilator effect in vitro. However, the use of polyphenol-rich CME in the treatment of hypertension-induced cardiac hypertrophy has not been reported. Objective: We investigated the effect of polyphenol-rich CME on hypertension-induced cardiac hypertrophy in rats and its possible mechanism of action. Materials and methods: The Sprague-Dawley rat model with cardiac hypertrophy was induced by renovascular hypertension. The blood pressure, cardiac weight index, free fatty acids (FFA) in serum and myocardium, and protein expressions of myocardial hypoxia inducible factor-1 alpha (HIF-1 alpha), peroxisome proliferator-activated receptor alpha (PPAR alpha), carnitine palmitoyltransferase-1a (CPT-1a), pyruvate dehydrogenase kinase-4 (PDK-4) and glucose transporter-4 (GLUT-4) were measured after treating hypertensive rats with polyphenol-rich CME of anthodia 75-150 mg/kg once daily for 4 weeks. A myocardial histological examination was also conducted. Results: After CME treatment, the blood pressure, cardiac weight and cardiac weight index decreased by 5.7-9.6%, 9.2-18.4% and 10.9-20.1%, respectively, and the cardiomyocyte cross-sectional area also decreased by 8.3-30.4%. The CME treatment simultaneously decreased the FFA in serum and myocardium and protein expressions of myocardial HIF-1 alpha and GLUT-4, and increased the protein expressions of myocardial PPAR alpha, CPT-1a and PDK-4, especially in the CME 150 mg/kg group (p<0.05 or p<0.01). Discussion and conclusion: Polyphenol-rich CME may alleviate hypertensive cardiac hypertrophy in rats. Its mechanisms may be related to the reduction of blood pressure and amelioration of the myocardial energy metabolism. The latter may be attributed to the inhibition of HIF-1 alpha expression and subsequent modulation of PPAR alpha-mediated CPT-1a, PDK-4 and GLUT-4 expressions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available